- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.81 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.3: 6 residues within 4Å:- Chain A: L.430, N.433, P.551, Q.608, D.609, D.611
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.609, A:D.611
NAG-NAG-BMA-MAN.28: 6 residues within 4Å:- Chain B: L.430, N.433, P.551, Q.608, D.609, D.611
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.609, B:D.611
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.4: 10 residues within 4Å:- Chain A: S.588, S.591, A.592, N.595, Q.697
- Chain B: L.67, H.69, E.233, Y.234, R.311
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.233, B:R.311, B:R.311, B:H.69
- Water bridges: B:H.69, B:L.67
NAG-NAG-BMA-MAN-MAN.29: 10 residues within 4Å:- Chain A: L.67, H.69, E.233, Y.234, R.311
- Chain B: S.588, S.591, A.592, N.595, Q.697
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.233, A:R.311, A:R.311, A:H.69
- Water bridges: A:H.69, A:L.67
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 4 residues within 4Å:- Chain A: N.78, T.80, H.81, T.306
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.306
- Hydrogen bonds: A:T.80
NAG.6: 2 residues within 4Å:- Chain A: N.152, S.154
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.154
NAG.7: 4 residues within 4Å:- Chain A: W.203, N.416, F.522, Y.523
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.203, A:Y.523
- Hydrogen bonds: A:W.203, A:F.522
- Water bridges: A:N.416
NAG.30: 4 residues within 4Å:- Chain B: N.78, T.80, H.81, T.306
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:T.306
- Hydrogen bonds: B:T.80
NAG.31: 2 residues within 4Å:- Chain B: N.152, S.154
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.154
NAG.32: 4 residues within 4Å:- Chain B: W.203, N.416, F.522, Y.523
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:W.203, B:Y.523
- Hydrogen bonds: B:W.203, B:F.522
- Water bridges: B:N.416
- 4 x ZN: ZINC ION(Non-covalent)
ZN.8: 5 residues within 4Å:- Chain A: D.344, E.382, H.510
- Ligands: ZN.9, FVZ.24
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.344, A:E.382, A:E.382, A:H.510, H2O.11
ZN.9: 6 residues within 4Å:- Chain A: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.8
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.334, A:D.344, A:D.410, A:D.410, H2O.11
ZN.33: 5 residues within 4Å:- Chain B: D.344, E.382, H.510
- Ligands: ZN.34, FVZ.49
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.344, B:E.382, B:E.382, B:H.510, H2O.27
ZN.34: 6 residues within 4Å:- Chain B: H.334, D.344, E.381, E.382, D.410
- Ligands: ZN.33
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.334, B:D.344, B:D.410, B:D.410, H2O.27
- 2 x CA: CALCIUM ION(Non-covalent)
CA.10: 4 residues within 4Å:- Chain A: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:T.226, A:Y.229, A:E.390, A:E.390, A:E.393
CA.35: 4 residues within 4Å:- Chain B: T.226, Y.229, E.390, E.393
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:T.226, B:Y.229, B:E.390, B:E.390, B:E.393
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.11: 4 residues within 4Å:- Chain A: N.408, D.410, R.491, R.493
Ligand excluded by PLIPCL.25: 4 residues within 4Å:- Chain A: Y.191, G.505, Y.509
- Ligands: FVZ.24
Ligand excluded by PLIPCL.36: 4 residues within 4Å:- Chain B: N.408, D.410, R.491, R.493
Ligand excluded by PLIPCL.50: 4 residues within 4Å:- Chain B: Y.191, G.505, Y.509
- Ligands: FVZ.49
Ligand excluded by PLIP- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.12: 3 residues within 4Å:- Chain A: D.566, K.567, S.570
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.570
- Water bridges: A:D.566, A:D.566
EDO.13: 4 residues within 4Å:- Chain A: E.25, K.28, P.525, M.526
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.25, A:P.525
- Water bridges: A:E.25
EDO.14: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)EDO.15: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)EDO.16: 3 residues within 4Å:- Chain A: K.281, V.282, P.283
No protein-ligand interaction detected (PLIP)EDO.17: 2 residues within 4Å:- Chain A: E.44, F.47
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Y.313, A:Y.313
EDO.37: 3 residues within 4Å:- Chain B: D.566, K.567, S.570
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.570
- Water bridges: B:D.566, B:D.566
EDO.38: 4 residues within 4Å:- Chain B: E.25, K.28, P.525, M.526
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.25, B:P.525
- Water bridges: B:E.25
EDO.39: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)EDO.40: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)EDO.41: 3 residues within 4Å:- Chain B: K.281, V.282, P.283
No protein-ligand interaction detected (PLIP)EDO.42: 2 residues within 4Å:- Chain B: E.44, F.47
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Y.313, B:Y.313
- 4 x TAM: TRIS(HYDROXYETHYL)AMINOMETHANE(Non-covalent)
TAM.18: 6 residues within 4Å:- Chain A: T.226, P.227, Y.229, R.238
- Chain B: L.636, R.687
6 PLIP interactions:3 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:L.636, A:P.227
- Hydrogen bonds: B:R.687, B:R.687, A:R.238
- Water bridges: A:Y.229
TAM.19: 4 residues within 4Å:- Chain A: S.458, R.468, S.470, W.498
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.498
- Hydrogen bonds: A:S.458
TAM.43: 6 residues within 4Å:- Chain A: L.636, R.687
- Chain B: T.226, P.227, Y.229, R.238
6 PLIP interactions:3 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:P.227, A:L.636
- Hydrogen bonds: B:R.238, A:R.687, A:R.687
- Water bridges: B:Y.229
TAM.44: 4 residues within 4Å:- Chain B: S.458, R.468, S.470, W.498
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.498
- Hydrogen bonds: B:S.458
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.20: 6 residues within 4Å:- Chain A: Y.328, W.391, L.398
- Chain B: E.701, E.705, V.706
No protein-ligand interaction detected (PLIP)PEG.21: 4 residues within 4Å:- Chain A: Y.582, S.679, G.683
- Chain B: Y.236
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.679
PEG.22: 3 residues within 4Å:- Chain A: L.40, G.42, K.79
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.79
- Water bridges: A:D.113
PEG.45: 6 residues within 4Å:- Chain A: E.701, E.705, V.706
- Chain B: Y.328, W.391, L.398
No protein-ligand interaction detected (PLIP)PEG.46: 4 residues within 4Å:- Chain A: Y.236
- Chain B: Y.582, S.679, G.683
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.679
PEG.47: 3 residues within 4Å:- Chain B: L.40, G.42, K.79
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.79
- Water bridges: B:D.113
- 2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
PGE.23: 11 residues within 4Å:- Chain A: D.326, R.327, E.401, R.402, F.627
- Chain B: R.327, D.623, Q.624, F.627, T.702
- Ligands: PGE.48
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.327, A:R.327, A:R.402, B:D.623
PGE.48: 11 residues within 4Å:- Chain A: R.327, D.623, Q.624, F.627, T.702
- Chain B: D.326, R.327, E.401, R.402, F.627
- Ligands: PGE.23
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.327, B:R.327, B:R.402, A:D.623
- 2 x FVZ: (2~{S})-2-[[(2~{S})-6-[(4-fluorophenyl)amino]-1-oxidanyl-1,6-bis(oxidanylidene)hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)
FVZ.24: 22 residues within 4Å:- Chain A: K.164, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, G.475, N.476, R.491, R.493, F.503, S.504, G.505, Y.509, H.510, K.656, Y.657
- Ligands: ZN.8, CL.25
20 PLIP interactions:20 interactions with chain A- Hydrophobic interactions: A:Y.509, A:Y.657
- Hydrogen bonds: A:N.214, A:G.475, A:G.475, A:G.475, A:N.476, A:G.505, A:Y.509
- Water bridges: A:N.214, A:D.344, A:D.344, A:R.420, A:R.491, A:K.656
- Salt bridges: A:R.167, A:R.491, A:R.493, A:H.510, A:K.656
FVZ.49: 22 residues within 4Å:- Chain B: K.164, F.166, R.167, N.214, D.344, E.381, E.382, G.384, L.385, G.475, N.476, R.491, R.493, F.503, S.504, G.505, Y.509, H.510, K.656, Y.657
- Ligands: ZN.33, CL.50
20 PLIP interactions:20 interactions with chain B- Hydrophobic interactions: B:Y.509, B:Y.657
- Hydrogen bonds: B:N.214, B:G.475, B:G.475, B:G.475, B:N.476, B:G.505, B:Y.509
- Water bridges: B:N.214, B:D.344, B:D.344, B:R.420, B:R.491, B:K.656
- Salt bridges: B:R.167, B:R.491, B:R.493, B:H.510, B:K.656
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakajima, R. et al., 2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics. ACS Med Chem Lett (2018)
- Release Date
- 2018-12-05
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.81 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 12 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 4 x TAM: TRIS(HYDROXYETHYL)AMINOMETHANE(Non-covalent)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 2 x FVZ: (2~{S})-2-[[(2~{S})-6-[(4-fluorophenyl)amino]-1-oxidanyl-1,6-bis(oxidanylidene)hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nakajima, R. et al., 2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics. ACS Med Chem Lett (2018)
- Release Date
- 2018-12-05
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A